Tuesday March 7, 9:25 am Eastern Time
Company Press Release
William R. Grant Appointed Vice Chairman Of Vasogen's Board Of Directors
TORONTO--(BW HealthWire)--Mar. 7, 2000--Vasogen Inc. (TSE:VAS. - news; AMEX:MEW - news) is pleased to announce the appointment of William R. Grant as Vice Chairman of its Board of Directors.
Mr. Grant, who joined Vasogen's Board of Directors in 1998, is Chairman of Galen Associates, a New York-based private equity and investment firm, which he co-founded in 1987 and which focuses solely on the healthcare industry. Galen has financed and assisted in the development of 45 healthcare companies. Mr. Grant has more than 40 years of experience in the investment banking and healthcare fields, including 24 years as a director of SmithKline Beecham from which he recently retired as Vice Chairman. During his 25 years with Smith Barney, where he participated in the financing of many healthcare companies, including G. D. Searle (now part of Monsanto), A. H. Robins (now American Home Products), Marion Laboratories (now Aventis), American Hospital Supply (now Baxter), and SmithKline Beecham (now Glaxo SmithKline), he rose to the office of President and then Vice Chairman.
Dr. William Cochrane, Vasogen's Chairman stated: ``I am delighted that Bill has chosen to take an increasingly active role in the Company. His extensive healthcare and capital markets experience has already had a beneficial impact on efforts to enhance shareholder value. As we expand development activities in the U.S., Bill will be a strong addition to the Vasogen team.'
In addition to his role as Vice Chairman of Vasogen's Board of Directors, Mr. Grant serves on a number of boards in the healthcare field, including Allergan, Inc.; MiniMed, Inc.; Ocular Sciences, Inc; and Quest Diagnostics and is a Trustee of The Center for Blood Research in Boston. |
